PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Key found to restoring 'exhausted' HIV-fighting immune cells

Protein could prove a promising new drug target

2013-12-02
(Press-News.org) Contact information: Shawna Williams
shawna@jhmi.edu
443-903-7607
Johns Hopkins Medicine
Key found to restoring 'exhausted' HIV-fighting immune cells Protein could prove a promising new drug target Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

"A large part of the reason we lose wars against viruses that cause chronic infection is that immune cells called T cells get turned off," says Jonathan Schneck, M.D., Ph.D., a professor of pathology in the Johns Hopkins Institute for Cell Engineering, who led the study. "We've been trying for some time to find out why that is, and in our study we were able to identify a family of proteins called Sprouty, specifically Sprouty-2, as a culprit."

T cells, a type of white blood cell, are programmed to recognize and kill cells infected with a specific virus or other disease-causing agent. Doing so effectively requires a T cell to perform multiple functions — par for the course when the cells are fighting a fresh infection. But when infection drags on, as HIV does, T cells often become "exhausted," losing two or more functions, except among so-called "elite suppressors" — rare HIV-infected patients whose T cells never seem to tire.

To investigate the source of exhaustion, the Johns Hopkins team first sought a way to recreate that phenomenon in the laboratory. Yen-Ling Chiu, M.D., a graduate student in Schneck's laboratory, was able to simulate the effects of long-term chronic infection by growing influenza-fighting T cells and dosing them with large amounts of antigen, a type of molecule that, like a red flag waved at a bull, signals immune cells to attack. Doing this "made the T cells dysfunctional — they looked like exhausted T cells in HIV," Chiu says.

Chiu next looked for differences in proteins made in the dysfunctional cells compared to those in fresh T cells. It turned out, he says, that many of the proteins whose quantities were different between the two groups of cells were involved in a biochemical chain of events called the MAPK/ERK pathway. That pathway controls a variety of important processes, such as cell division. One of the proteins that was more abundant in the exhausted T cells than in the fresh T cells was Sprouty-2, which, other studies had shown, slows down the MAPK/ERK pathway. Suspecting that Sprouty-2 could be the culprit in T cell exhaustion, Chiu used a specially engineered virus to disable the Sprouty-2 gene in some T cells and found that they were more likely to retain all of their functions than were the cells with working Sprouty-2.

"It was a surprise to find T cell exhaustion controlled by such a central pathway, and especially that it worked in such a highly fine-tuned way, keeping some T cell functions going but not others," says Schneck.

Though the finding was intriguing, Schneck says, "the real test was whether it held up in blood samples from HIV patients." In one experiment, reducing the amount of Sprouty-2 in exhausted HIV-fighting T cells partially restored them, the researchers found. Drawing on the work of other groups, which had shown that reducing the amount of another protein, called PD-1, modestly improved the function of exhausted T cells, the research team next tried disabling both Sprouty-2 and PD-1 in the HIV-fighting cells. "That reversed the exhaustion completely," Schneck says.

"By identifying Sprouty-2 and related proteins as potential targets, these results support the idea that immunotherapy may someday lead to a functional cure for HIV-1 infection," says Joel Blankson, M.D., Ph.D., an associate professor in the Department of Medicine's Division of Infectious Diseases, who also took part in the study.

There are no known chemical compounds that can block Sprouty-2 in living animals, so Schneck's group plans to begin looking for one — a first step toward potentially developing new drugs based on the discovery. Schneck notes that they will also investigate whether Sprouty proteins cause exhaustion in T cells fighting other chronic infections, such as tuberculosis and hepatitis C.

### Other authors on the paper are Liang Shan, Carl Haupt, Catherine Bessell, Hao Zhang, Ya-Chi Ho, Jonathan D. Powell, Mathias Oelke, Joseph B. Margolick, Joel N. Blankson and Diane E. Griffin of Johns Hopkins University; Hailiang Huang of Far-Eastern Memorial Hospital in Taiwan; and David H. Canaday of Case Western Reserve University.

The study was funded by the National Cancer Institute (grant number RO1 CA 108835), the National Institute of Allergy and Infectious Diseases (grant numbers PO1 AI072677, AI 080313 and AI 36219), the Department of Veterans Affairs Merit Review Award Program and the Bill and Melinda Gates Foundation.

Under a licensing agreement between NexImmune and the Johns Hopkins University, Drs. Schneck and Oelke are entitled to shares of royalty received by the University on sales of products described in this article. They also own NexImmune stock, which is subject to certain restrictions under University policy. Dr. Schneck is a member of the company's Board of Directors and Scientific Advisory Board. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.

Related stories: Jonathan Schneck on designing an artificial cell that conducts the symphony of the immune system http://www.hopkinsmedicine.org/institute_cell_engineering/experts/meet_scientists/jonathan_schneck.html Football-shaped Particles Bolster the Body's Defense Against Cancer http://www.hopkinsmedicine.org/news/media/releases/football_shaped_particles_bolster_the_bodys_defense_against_cancer Immune System "Escape Hatch" Gives Cancer Cells Traction http://www.hopkinsmedicine.org/news/media/releases/immune_system_escape_hatch_gives_cancer_cells_traction Curing HIV/AIDS Gets Tougher: Study Shows Far More "Hidden" and Potentially Active Virus than Once Thought http://www.hopkinsmedicine.org/news/media/releases/curing_hivaids_gets_tougher_study_shows_far_more_hidden_and_potentially_active_virus_than_once_thought


ELSE PRESS RELEASES FROM THIS DATE:

New evidence that 'gout' strongly runs in the family

2013-12-02
New evidence that 'gout' strongly runs in the family It's historically known as 'the king of diseases and the disease of kings' and was long thought to be caused by an overindulgent lifestyle, but now scientists at The University of Nottingham have confirmed ...

Researchers analyze growth potential in African bank loans

2013-12-02
Researchers analyze growth potential in African bank loans In Africa, small women-owned business owners find it easier to obtain loans than their male counterparts. The reason for this distortion is that politicians and foreign aid organisations with their focus on bank ...

Congenital heart defects affects long-term developmental outcome

2013-12-02
Congenital heart defects affects long-term developmental outcome Approximately one percent of all newborns in Switzerland are diagnosed with a congenital heart defect, roughly half of them require open heart surgery. Most children, including those with the most severe ...

New research shows obesity is an inflammatory disease

2013-12-02
New research shows obesity is an inflammatory disease New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and ...

EASAC report warns Europe on extreme weather event increase

2013-12-02
EASAC report warns Europe on extreme weather event increase First comprehensive survey shows 60 percent rise over last 30 years of floods, droughts and storms Europe needs to plan for future probabilities of extreme weather. Heat waves, ...

Athletes and the words for actions

2013-12-02
Athletes and the words for actions A study investigates the role of the motor system in conceptualization Is it true, as some scientists believe, that to understand words like "spike" (in the volleyball sense) the brain has to "mentally" ...

IQWiG publishes new version of its General Methods

2013-12-02
IQWiG publishes new version of its General Methods Procedure for report production and section on meta-analyses updated / New sections on early benefit assessment The German Institute for Quality and Efficiency in Health Care (IQWiG) ...

Detailed image shows how genomes are copied

2013-12-02
Detailed image shows how genomes are copied For the first time, researchers at Umeå University have succeeded in showing how the DNA polymerase epsilon enzyme builds new genomes. The detailed image produced by these researchers shows how ...

The importance of standardizing drug screening studies

2013-12-02
The importance of standardizing drug screening studies An IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies Montréal, December 2, 2013 – A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently ...

Nanorobot for transporting drugs in the body

2013-12-02
Nanorobot for transporting drugs in the body A nanorobot is a popular term for molecules with a unique property that enables them to be programmed to carry out a specific task. In collaboration with colleagues in Italy and the USA, researchers at Aarhus University have ...

LAST 30 PRESS RELEASES:

Public confidence in U.S. health agencies slides, fueled by declines among Democrats

“Quantum squeezing” a nanoscale particle for the first time

El Niño spurs extreme daily rain events despite drier monsoons in India

Two studies explore the genomic diversity of deadly mosquito vectors

Zebra finches categorize their vocal calls by meaning

Analysis challenges conventional wisdom about partisan support for US science funding

New model can accurately predict a forest’s future

‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance

Genomic evolution of major malaria-transmitting mosquito species uncovered

Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery

Tuberculosis vulnerability of people with HIV: a viral protein implicated

Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living

Decoding the selfish gene, from evolutionary cheaters to disease control

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

[Press-News.org] Key found to restoring 'exhausted' HIV-fighting immune cells
Protein could prove a promising new drug target